Context There have been substantial changes in the management of men with metastatic
hormone-sensitive prostate cancer (mHSPC) over the past 5 yr, with upfront combination …

Prostate-specific membrane antigen (PSMA) PET/CT is a novel imaging technique for the
detection and staging of either primary or recurrent prostate cancer. Early studies …

Purpose Prostate-specific membrane antigen (PSMA) PET/CT is increasingly used in patients
with biochemical recurrence post prostatectomy to detect local recurrence and metastatic …

Objectives To assess the accuracy of multiparametric magnetic resonance imaging (mp MRI
) for the detection of significant prostate cancer in men undergoing radical prostatectomy ( …

PSMA PET/CT is rapidly altering the landscape of primary staging in PCa. It appears to be
superior to conventional imaging for detecting regional and distant metastasis, though caution …

Objectives To review current data for the role of prostate specific membrane antigen (PSMA)
radioligand therapy (RLT) for patients with advanced prostate cancer. This review provides …

Background To determine the utility of diagnostic 18F-DCPyL PSMA-PET/CT to aid management
of men with highly suspicious multiparametric MRI prostate (PIRAD 4–5 lesions) and …

In urological oncology, the use of 18 F-FDG has been limited by a generally low tumor
uptake and physiological 18 F-FDG excretion by the urinary system. Other radiotracers are …

Radical inguinal orchidectomy with division of the spermatic cord at the internal inguinal
ring is the gold standard for diagnosis and local treatment of testicular malignancies. The …

Prostate-specific membrane antigen (PSMA) tracers have increased sensitivity in the detection
of prostate cancer, compared with conventional imaging. We assessed the management …